Maternal-fetal Outcomes of Women with Hypertensive Disorders of Pregnancy

Overview

Journal Rev Assoc Med Bras (1992)

Specialty General Medicine

Date 2023 Jun 7

PMID 37283361

Authors

Ivete Matias Xavier

Ana Carolina Zimmermann Simoes

Ronnier de Oliveira

Yasha Emerenciano Barros

Ayane Cristine Alves Sarmento

Kleyton Santos de Medeiros

Ana Paula Ferreira Costa

Henri Korkes

Ana Katherine Goncalves

Affiliations

Soon will be listed here.

Abstract

Objective: The objective of this study was to determine adverse maternal and perinatal outcomes in pregnant women with hypertensive disorders of pregnancy.

Methods: An analytical cross-sectional study was conducted on women admitted with hypertensive disorders of pregnancies to a university maternity hospital from August 2020 to August 2022. Data were collected using a pretested structured questionnaire. Variables associated with adverse maternal and perinatal outcomes were compared using multivariable binomial regression.

Results: Of 501 women with pregnancies, 2, 35, 14, and 49% had eclampsia, preeclampsia, chronic hypertension, and gestational hypertension, respectively. Women with preeclampsia/eclampsia had significantly higher risks of cesarean section (79.4 vs. 65%; adjusted RR, 2,139; 95%CI, 1,386-3,302; p=0.001) and preterm delivery at <34 weeks' gestation (20.5 vs. 6%; adjusted RR, 2.5; 95%CI, 1.19-5.25; p=0.01) than those of women with chronic/gestational hypertension. Risks of prolonged maternal hospitalization (43.9 vs. 27.1%), neonatal intensive care unit admission (30.7 vs. 19.8%), and perinatal mortality (23.5 vs. 11.2%) were higher among women with preeclampsia/eclampsia.

Conclusions: Women with preeclampsia/eclampsia had a higher risk of adverse maternal and neonatal outcomes than those with chronic or gestational hypertension. This major maternity care center requires strategies for preventing and managing preeclampsia/eclampsia to improve pregnancy outcomes.

Citing Articles

The Impact of Maternal Chronic Inflammatory Conditions on Breast Milk Composition: Possible Influence on Offspring Metabolic Programming.

Arenas G, Barrera M, Contreras-Duarte S Nutrients. 2025; 17(3).

PMID: 39940245 PMC: 11820913. DOI: 10.3390/nu17030387.

Could signal peptide complement C1r/C1s, Uegf, and Bmp1, and epidermal growth factor-containing protein 1 be a therapeutic target in the pathogenesis of preeclampsia?.

Toprak K, Yildiz Z, Akdemir S, Esen K, Duken R Rev Assoc Med Bras (1992). 2024; 70(3):e20231027.

PMID: 38451587 PMC: 10914331. DOI: 10.1590/1806-9282.20231027.

Comment on "Maternal-fetal outcomes of women with hypertensive disorders of pregnancy".

Yang X, Wang G Rev Assoc Med Bras (1992). 2024; 70(2):e20231285.

PMID: 38451580 PMC: 10913777. DOI: 10.1590/1806-9282.20231285.

References

Goes A, Oliveira A, de Andrade T, Alves B, Felizardo Neves S, Dias J . Influence of drug-related problems on length of hospital stay of women with a history of preeclampsia: A multicenter study. Pregnancy Hypertens. 2021; 27:8-13. DOI: 10.1016/j.preghy.2021.11.005. View

Adu-Bonsaffoh K, Ntumy M, Obed S, Seffah J . Perinatal outcomes of hypertensive disorders in pregnancy at a tertiary hospital in Ghana. BMC Pregnancy Childbirth. 2017; 17(1):388. PMC: 5696910. DOI: 10.1186/s12884-017-1575-2. View

. ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia. Obstet Gynecol. 2018; 133(1):1. DOI: 10.1097/AOG.0000000000003018. View

Razak A, Florendo-Chin A, Banfield L, Abdul Wahab M, McDonald S, Shah P . Pregnancy-induced hypertension and neonatal outcomes: a systematic review and meta-analysis. J Perinatol. 2017; 38(1):46-53. DOI: 10.1038/jp.2017.162. View

Wertaschnigg D, Selvaratnam R, Rolnik D, Davey M, Anil S, Mol B . Hypertensive disorders in pregnancy - Trends over eight years: A population-based cohort study. Pregnancy Hypertens. 2022; 28:60-65. DOI: 10.1016/j.preghy.2022.02.006. View

Ndwiga C, Odwe G, Pooja S, Ogutu O, Osoti A, Warren C . Clinical presentation and outcomes of pre-eclampsia and eclampsia at a national hospital, Kenya: A retrospective cohort study. PLoS One. 2020; 15(6):e0233323. PMC: 7274433. DOI: 10.1371/journal.pone.0233323. View

Torosyan N, Aziz D, Quesada O . Long-term sequelae of adverse pregnancy outcomes. Maturitas. 2022; 165:1-7. DOI: 10.1016/j.maturitas.2022.06.012. View

Preston E, Hivert M, Fleisch A, Calafat A, Sagiv S, Perng W . Early-pregnancy plasma per- and polyfluoroalkyl substance (PFAS) concentrations and hypertensive disorders of pregnancy in the Project Viva cohort. Environ Int. 2022; 165:107335. PMC: 9348856. DOI: 10.1016/j.envint.2022.107335. View

Metoki H, Iwama N, Hamada H, Satoh M, Murakami T, Ishikuro M . Hypertensive disorders of pregnancy: definition, management, and out-of-office blood pressure measurement. Hypertens Res. 2022; 45(8):1298-1309. PMC: 9207424. DOI: 10.1038/s41440-022-00965-6. View

10.

Ford N, Cox S, Ko J, Ouyang L, Romero L, Colarusso T . Hypertensive Disorders in Pregnancy and Mortality at Delivery Hospitalization - United States, 2017-2019. MMWR Morb Mortal Wkly Rep. 2022; 71(17):585-591. PMC: 9098235. DOI: 10.15585/mmwr.mm7117a1. View

11.

von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008; 61(4):344-9. DOI: 10.1016/j.jclinepi.2007.11.008. View

12.

Antza C, Stabouli S, Kotsis V . Practical guide for the management of hypertensive disorders during pregnancy. J Hypertens. 2022; 40(7):1257-1264. DOI: 10.1097/HJH.0000000000003194. View

13.

Dassah E, Kusi-Mensah E, Morhe E, Odoi A . Maternal and perinatal outcomes among women with hypertensive disorders in pregnancy in Kumasi, Ghana. PLoS One. 2019; 14(10):e0223478. PMC: 6777792. DOI: 10.1371/journal.pone.0223478. View

14.

Magee L, Brown M, Hall D, Gupte S, Hennessy A, Karumanchi S . The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2022; 27:148-169. DOI: 10.1016/j.preghy.2021.09.008. View

15.

Amorim M, Souza A, Katz L . Planned caesarean section versus planned vaginal birth for severe pre-eclampsia. Cochrane Database Syst Rev. 2017; 10:CD009430. PMC: 6485640. DOI: 10.1002/14651858.CD009430.pub2. View

16.

Rush D . Nutrition and maternal mortality in the developing world. Am J Clin Nutr. 2000; 72(1 Suppl):212S-240S. DOI: 10.1093/ajcn/72.1.212S. View

17.

Lutsey P, Dawe D, Villate E, Valencia S, Lopez O . Iron supplementation compliance among pregnant women in Bicol, Philippines. Public Health Nutr. 2007; 11(1):76-82. DOI: 10.1017/S1368980007000237. View

18.

Amare M, Olani A, Hassen H, Jiregna B, Getachew N, Belina S . Perinatal Outcomes and Associated Factors among women with hypertensive Disorders of Pregnancy Delivered in Jimma Zone Hospitals, Southwest Ethiopia. Ethiop J Health Sci. 2022; 31(6):1145-1154. PMC: 8968375. DOI: 10.4314/ejhs.v31i6.9. View

19.

Blanco E, Marin M, Nunez L, Retamal E, Ossa X, Woolley K . Adverse pregnancy and perinatal outcomes in Latin America and the Caribbean: systematic review and meta-analysis. Rev Panam Salud Publica. 2022; 46:e21. PMC: 9060182. DOI: 10.26633/RPSP.2022.21. View

20.

Chih H, Elias F, Gaudet L, Velez M . Assisted reproductive technology and hypertensive disorders of pregnancy: systematic review and meta-analyses. BMC Pregnancy Childbirth. 2021; 21(1):449. PMC: 8240295. DOI: 10.1186/s12884-021-03938-8. View